0.010482
0.006052
0.000000
0.000000
0.012104
0.000000
0.000000
0.000000
0.007645
0.00000
0.00000
0.00000
Maenaka, K.
Juji, T.
Stuart, D.I.
Jones, E.Y.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
12
90.00
90.00
120.00
95.400
95.400
130.800
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure Fold.Des.
FODEFH
1263
0969-2126
7
391
398
10.1016/S0969-2126(99)80052-5
10196125
Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I.
1999
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
288
1
MIRRORS
IMAGE PLATE
1996-10
FUJI
SINGLE WAVELENGTH
M
x-ray
1
1.0
1.0
BL-6A
Photon Factory
1.0
1.0
SYNCHROTRON
PHOTON FACTORY BEAMLINE BL-6A
28189.141
P58 KILLER CELL INHIBITORY RECEPTOR
EXTRACELLULAR REGION
1
man
polymer
KIR2DL3
no
no
HEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFQHFLLHREGKFKDTLHLIGEHHDGVSKANFSIGPMMQDLAGTYRCY
GSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHLSREGEAHERRFSAGPKVNGTF
QADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPSNSWPSPTEPSSETGNPRHLHAAAEQKLISEEDLNLD
LVPRGSSSHHHHHHSSG
HEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFQHFLLHREGKFKDTLHLIGEHHDGVSKANFSIGPMMQDLAGTYRCY
GSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHLSREGEAHERRFSAGPKVNGTF
QADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPSNSWPSPTEPSSETGNPRHLHAAAEQKLISEEDLNLD
LVPRGSSSHHHHHHSSG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
CLONING BY PCR
NATURAL KILLER CELL
BL21
CELL SURFACE
NKAT2
9606
Homo sapiens
MEDIA AND PERIPLASMIC SPACE
NKAT2
562
Escherichia coli
BL21 PLYSS
ESCHERICHIA COLI
PLASMID
PKMATHNK2
1
3.05
60
DATA WERE COLLECTED USING WEISSENBERG METHOD.
7.5
pH 7.5
diffrn_radiation
diffrn_source
repository
Initial release
Version format compliance
Version format compliance
Data collection
1
0
1999-01-27
1
1
2008-03-24
1
2
2011-07-13
1
3
2018-06-13
_diffrn_radiation.pdbx_diffrn_protocol
_diffrn_source.pdbx_wavelength_list
Y
BNL
1999-01-18
REL
REL
n
1
1
A
n
2
2
A
n
3
3
A
n
4
4
A
HIS
5
n
5
HIS
5
A
ARG
6
n
6
ARG
6
A
LYS
7
n
7
LYS
7
A
PRO
8
n
8
PRO
8
A
SER
9
n
9
SER
9
A
LEU
10
n
10
LEU
10
A
LEU
11
n
11
LEU
11
A
ALA
12
n
12
ALA
12
A
HIS
13
n
13
HIS
13
A
PRO
14
n
14
PRO
14
A
GLY
15
n
15
GLY
15
A
PRO
16
n
16
PRO
16
A
LEU
17
n
17
LEU
17
A
VAL
18
n
18
VAL
18
A
LYS
19
n
19
LYS
19
A
SER
20
n
20
SER
20
A
GLU
21
n
21
GLU
21
A
GLU
22
n
22
GLU
22
A
THR
23
n
23
THR
23
A
VAL
24
n
24
VAL
24
A
ILE
25
n
25
ILE
25
A
LEU
26
n
26
LEU
26
A
GLN
27
n
27
GLN
27
A
CYS
28
n
28
CYS
28
A
TRP
29
n
29
TRP
29
A
SER
30
n
30
SER
30
A
ASP
31
n
31
ASP
31
A
VAL
32
n
32
VAL
32
A
ARG
33
n
33
ARG
33
A
PHE
34
n
34
PHE
34
A
GLN
35
n
35
GLN
35
A
HIS
36
n
36
HIS
36
A
PHE
37
n
37
PHE
37
A
LEU
38
n
38
LEU
38
A
LEU
39
n
39
LEU
39
A
HIS
40
n
40
HIS
40
A
ARG
41
n
41
ARG
41
A
GLU
42
n
42
GLU
42
A
GLY
43
n
43
GLY
43
A
LYS
44
n
44
LYS
44
A
PHE
45
n
45
PHE
45
A
LYS
46
n
46
LYS
46
A
ASP
47
n
47
ASP
47
A
THR
48
n
48
THR
48
A
LEU
49
n
49
LEU
49
A
HIS
50
n
50
HIS
50
A
LEU
51
n
51
LEU
51
A
ILE
52
n
52
ILE
52
A
GLY
53
n
53
GLY
53
A
GLU
54
n
54
GLU
54
A
HIS
55
n
55
HIS
55
A
HIS
56
n
56
HIS
56
A
ASP
57
n
57
ASP
57
A
GLY
58
n
58
GLY
58
A
VAL
59
n
59
VAL
59
A
SER
60
n
60
SER
60
A
LYS
61
n
61
LYS
61
A
ALA
62
n
62
ALA
62
A
ASN
63
n
63
ASN
63
A
PHE
64
n
64
PHE
64
A
SER
65
n
65
SER
65
A
ILE
66
n
66
ILE
66
A
GLY
67
n
67
GLY
67
A
PRO
68
n
68
PRO
68
A
MET
69
n
69
MET
69
A
MET
70
n
70
MET
70
A
GLN
71
n
71
GLN
71
A
ASP
72
n
72
ASP
72
A
LEU
73
n
73
LEU
73
A
ALA
74
n
74
ALA
74
A
GLY
75
n
75
GLY
75
A
THR
76
n
76
THR
76
A
TYR
77
n
77
TYR
77
A
ARG
78
n
78
ARG
78
A
CYS
79
n
79
CYS
79
A
TYR
80
n
80
TYR
80
A
GLY
81
n
81
GLY
81
A
SER
82
n
82
SER
82
A
VAL
83
n
83
VAL
83
A
THR
84
n
84
THR
84
A
HIS
85
n
85
HIS
85
A
SER
86
n
86
SER
86
A
PRO
87
n
87
PRO
87
A
TYR
88
n
88
TYR
88
A
GLN
89
n
89
GLN
89
A
LEU
90
n
90
LEU
90
A
SER
91
n
91
SER
91
A
ALA
92
n
92
ALA
92
A
PRO
93
n
93
PRO
93
A
SER
94
n
94
SER
94
A
ASP
95
n
95
ASP
95
A
PRO
96
n
96
PRO
96
A
LEU
97
n
97
LEU
97
A
ASP
98
n
98
ASP
98
A
ILE
99
n
99
ILE
99
A
VAL
100
n
100
VAL
100
A
ILE
101
n
101
ILE
101
A
THR
102
n
102
THR
102
A
GLY
103
n
103
GLY
103
A
LEU
104
n
104
LEU
104
A
TYR
105
n
105
TYR
105
A
GLU
106
n
106
GLU
106
A
LYS
107
n
107
LYS
107
A
PRO
108
n
108
PRO
108
A
SER
109
n
109
SER
109
A
LEU
110
n
110
LEU
110
A
SER
111
n
111
SER
111
A
ALA
112
n
112
ALA
112
A
GLN
113
n
113
GLN
113
A
PRO
114
n
114
PRO
114
A
GLY
115
n
115
GLY
115
A
PRO
116
n
116
PRO
116
A
THR
117
n
117
THR
117
A
VAL
118
n
118
VAL
118
A
LEU
119
n
119
LEU
119
A
ALA
120
n
120
ALA
120
A
GLY
121
n
121
GLY
121
A
GLU
122
n
122
GLU
122
A
SER
123
n
123
SER
123
A
VAL
124
n
124
VAL
124
A
THR
125
n
125
THR
125
A
LEU
126
n
126
LEU
126
A
SER
127
n
127
SER
127
A
CYS
128
n
128
CYS
128
A
SER
129
n
129
SER
129
A
SER
130
n
130
SER
130
A
ARG
131
n
131
ARG
131
A
SER
132
n
132
SER
132
A
SER
133
n
133
SER
133
A
TYR
134
n
134
TYR
134
A
ASP
135
n
135
ASP
135
A
MET
136
n
136
MET
136
A
TYR
137
n
137
TYR
137
A
HIS
138
n
138
HIS
138
A
LEU
139
n
139
LEU
139
A
SER
140
n
140
SER
140
A
ARG
141
n
141
ARG
141
A
GLU
142
n
142
GLU
142
A
GLY
143
n
143
GLY
143
A
GLU
144
n
144
GLU
144
A
ALA
145
n
145
ALA
145
A
HIS
146
n
146
HIS
146
A
GLU
147
n
147
GLU
147
A
ARG
148
n
148
ARG
148
A
ARG
149
n
149
ARG
149
A
PHE
150
n
150
PHE
150
A
SER
151
n
151
SER
151
A
ALA
152
n
152
ALA
152
A
GLY
153
n
153
GLY
153
A
PRO
154
n
154
PRO
154
A
LYS
155
n
155
LYS
155
A
VAL
156
n
156
VAL
156
A
ASN
157
n
157
ASN
157
A
GLY
158
n
158
GLY
158
A
THR
159
n
159
THR
159
A
PHE
160
n
160
PHE
160
A
GLN
161
n
161
GLN
161
A
ALA
162
n
162
ALA
162
A
ASP
163
n
163
ASP
163
A
PHE
164
n
164
PHE
164
A
PRO
165
n
165
PRO
165
A
LEU
166
n
166
LEU
166
A
GLY
167
n
167
GLY
167
A
PRO
168
n
168
PRO
168
A
ALA
169
n
169
ALA
169
A
THR
170
n
170
THR
170
A
HIS
171
n
171
HIS
171
A
GLY
172
n
172
GLY
172
A
GLY
173
n
173
GLY
173
A
THR
174
n
174
THR
174
A
TYR
175
n
175
TYR
175
A
ARG
176
n
176
ARG
176
A
CYS
177
n
177
CYS
177
A
PHE
178
n
178
PHE
178
A
GLY
179
n
179
GLY
179
A
SER
180
n
180
SER
180
A
PHE
181
n
181
PHE
181
A
ARG
182
n
182
ARG
182
A
ASP
183
n
183
ASP
183
A
SER
184
n
184
SER
184
A
PRO
185
n
185
PRO
185
A
TYR
186
n
186
TYR
186
A
GLU
187
n
187
GLU
187
A
TRP
188
n
188
TRP
188
A
SER
189
n
189
SER
189
A
ASN
190
n
190
ASN
190
A
SER
191
n
191
SER
191
A
SER
192
n
192
SER
192
A
ASP
193
n
193
ASP
193
A
PRO
194
n
194
PRO
194
A
LEU
195
n
195
LEU
195
A
LEU
196
n
196
LEU
196
A
VAL
197
n
197
VAL
197
A
SER
198
n
198
SER
198
A
VAL
199
n
199
VAL
199
A
THR
200
n
200
THR
200
A
GLY
201
n
201
GLY
201
A
ASN
202
n
202
ASN
202
A
PRO
203
n
203
PRO
203
A
n
204
204
A
n
205
205
A
n
206
206
A
n
207
207
A
n
208
208
A
n
209
209
A
n
210
210
A
n
211
211
A
n
212
212
A
n
213
213
A
n
214
214
A
n
215
215
A
n
216
216
A
n
217
217
A
n
218
218
A
n
219
219
A
n
220
220
A
n
221
221
A
n
222
222
A
n
223
223
A
n
224
224
A
n
225
225
A
n
226
226
A
n
227
227
A
n
228
228
A
n
229
229
A
n
230
230
A
n
231
231
A
n
232
232
A
n
233
233
A
n
234
234
A
n
235
235
A
n
236
236
A
n
237
237
A
n
238
238
A
n
239
239
A
n
240
240
A
n
241
241
A
n
242
242
A
n
243
243
A
n
244
244
A
n
245
245
A
n
246
246
A
n
247
247
A
n
248
248
A
n
249
249
A
n
250
250
A
n
251
251
A
n
252
252
A
n
253
253
A
n
254
254
A
n
255
255
A
n
256
256
A
n
257
257
A
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
-0.8660254038
0.0000000000
-0.8660254038
0.5000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
9_765
-x+2,-x+y+1,-z+1/3
crystal symmetry operation
143.1000000000
82.6188235210
43.6000000000
A
O
VAL
18
A
O
VAL
18
A
N
VAL
100
A
N
VAL
100
A
O
VAL
24
A
O
VAL
24
A
N
ILE
66
A
N
ILE
66
A
O
ASP
47
A
O
ASP
47
A
N
ARG
41
A
N
ARG
41
A
O
HIS
36
A
O
HIS
36
A
N
SER
82
A
N
SER
82
A
O
GLY
75
A
O
GLY
75
A
N
ILE
99
A
N
ILE
99
A
O
SER
109
A
O
SER
109
A
N
SER
129
A
N
SER
129
A
O
VAL
124
A
O
VAL
124
A
N
GLY
167
A
N
GLY
167
A
O
MET
136
A
O
MET
136
A
N
SER
180
A
N
SER
180
A
O
GLY
173
A
O
GLY
173
A
N
VAL
197
A
N
VAL
197
1
A
HIS
1
A
HIS
1
1
Y
1
A
GLU
2
A
GLU
2
1
Y
1
A
GLY
3
A
GLY
3
1
Y
1
A
VAL
4
A
VAL
4
1
Y
1
A
SER
204
A
SER
204
1
Y
1
A
ASN
205
A
ASN
205
1
Y
1
A
SER
206
A
SER
206
1
Y
1
A
TRP
207
A
TRP
207
1
Y
1
A
PRO
208
A
PRO
208
1
Y
1
A
SER
209
A
SER
209
1
Y
1
A
PRO
210
A
PRO
210
1
Y
1
A
THR
211
A
THR
211
1
Y
1
A
GLU
212
A
GLU
212
1
Y
1
A
PRO
213
A
PRO
213
1
Y
1
A
SER
214
A
SER
214
1
Y
1
A
SER
215
A
SER
215
1
Y
1
A
GLU
216
A
GLU
216
1
Y
1
A
THR
217
A
THR
217
1
Y
1
A
GLY
218
A
GLY
218
1
Y
1
A
ASN
219
A
ASN
219
1
Y
1
A
PRO
220
A
PRO
220
1
Y
1
A
ARG
221
A
ARG
221
1
Y
1
A
HIS
222
A
HIS
222
1
Y
1
A
LEU
223
A
LEU
223
1
Y
1
A
HIS
224
A
HIS
224
1
Y
1
A
ALA
225
A
ALA
225
1
Y
1
A
ALA
226
A
ALA
226
1
Y
1
A
ALA
227
A
ALA
227
1
Y
1
A
GLU
228
A
GLU
228
1
Y
1
A
GLN
229
A
GLN
229
1
Y
1
A
LYS
230
A
LYS
230
1
Y
1
A
LEU
231
A
LEU
231
1
Y
1
A
ILE
232
A
ILE
232
1
Y
1
A
SER
233
A
SER
233
1
Y
1
A
GLU
234
A
GLU
234
1
Y
1
A
GLU
235
A
GLU
235
1
Y
1
A
ASP
236
A
ASP
236
1
Y
1
A
LEU
237
A
LEU
237
1
Y
1
A
ASN
238
A
ASN
238
1
Y
1
A
LEU
239
A
LEU
239
1
Y
1
A
ASP
240
A
ASP
240
1
Y
1
A
LEU
241
A
LEU
241
1
Y
1
A
VAL
242
A
VAL
242
1
Y
1
A
PRO
243
A
PRO
243
1
Y
1
A
ARG
244
A
ARG
244
1
Y
1
A
GLY
245
A
GLY
245
1
Y
1
A
SER
246
A
SER
246
1
Y
1
A
SER
247
A
SER
247
1
Y
1
A
SER
248
A
SER
248
1
Y
1
A
HIS
249
A
HIS
249
1
Y
1
A
HIS
250
A
HIS
250
1
Y
1
A
HIS
251
A
HIS
251
1
Y
1
A
HIS
252
A
HIS
252
1
Y
1
A
HIS
253
A
HIS
253
1
Y
1
A
HIS
254
A
HIS
254
1
Y
1
A
SER
255
A
SER
255
1
Y
1
A
SER
256
A
SER
256
1
Y
1
A
GLY
257
A
GLY
257
1
Y
1
9.08
1.50
119.30
128.38
A
A
A
C
N
CA
GLY
PRO
PRO
153
154
154
Y
1
A
ARG
6
-38.50
165.49
1
A
GLU
21
61.05
-42.49
1
A
ARG
33
-95.74
36.74
1
A
LYS
44
-48.13
-86.28
1
A
LYS
46
-48.22
108.75
1
A
ASP
57
-13.71
118.84
1
A
PRO
68
-32.85
108.75
1
A
THR
84
-9.30
-72.40
1
A
HIS
85
-72.47
43.91
1
A
SER
86
155.18
51.86
1
A
PRO
87
-61.71
4.48
1
A
GLN
113
-175.19
133.91
1
A
VAL
118
-42.58
160.57
1
A
SER
133
-87.19
49.95
1
A
GLU
142
-15.16
101.12
1
A
GLU
144
-37.47
125.74
1
A
ALA
145
3.15
-88.41
1
A
PHE
150
-172.60
138.19
1
A
LYS
155
56.52
123.47
1
A
VAL
156
-158.66
-39.10
1
A
ASN
157
-157.27
29.83
1
A
ALA
169
-56.84
104.07
1
A
THR
170
-70.86
-90.44
1
A
ASP
183
-22.03
-72.01
40.8
-0.40
-4.12
0.00
-0.40
0.00
0.81
REFINED BY X-PLOR, REFMAC AND CN
0.32
0.248
0.248
3.0
15.0
354
5896
5
79.4
RANDOM
1
THROUGHOUT
0
MOLECULAR REPLACEMENT
FLAT MODEL
20
0.25
3.0
15.0
0
1541
0
0
1541
0.008
1.57
3.0
20.0
1B6U
6281
0
0.195
1
4.7
2.9
84.9
0.49
3.0
3.11
1.5
87.6
data reduction
DENZO
data scaling
SCALEPACK
refinement
CNS
0.5
phasing
CNS
0.5
P58 KILLER CELL INHIBITORY RECEPTOR
CRYSTAL STRUCTURE OF THE HUMAN KILLER CELL INHIBITORY RECEPTOR (KIR2DL3) SPECIFIC FOR HLA-CW3 RELATED ALLELES
1
N
N
disulf
2.015
A
CYS
28
A
SG
CYS
28
1_555
A
CYS
79
A
SG
CYS
79
1_555
disulf
2.029
A
CYS
128
A
SG
CYS
128
1_555
A
CYS
177
A
SG
CYS
177
1_555
KILLER CELL INHIBITORY RECEPTOR
KILLER CELL INHIBITORY RECEPTOR, NATURAL KILLER CELL, HLA, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I (MHC CLASS I), CELL SURFACE RECEPTOR, IMMUNOGLOBULIN SUPERFAMILY
A
HIS
13
A
HIS
13
1
A
PRO
14
A
PRO
14
0.07
A
GLN
113
A
GLN
113
1
A
PRO
114
A
PRO
114
0.19
KI2L3_HUMAN
UNP
1
1
P43628
MSLMVVSMVCVGFFLLQGAWPHEGVHRKPSLLAHPGPLVKSEETVILQCWSDVRFQHFLLHREGKFKDTLHLIGEHHDGV
SKANFSIGPMMQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVITGLYEKPSLSAQPGPTVLAGESVTLSCSSRSSYDMYHL
SREGEAHERRFSAGPKVNGTFQADFPLGPATHGGTYRCFGSFRDSPYEWSNSSDPLLVSVTGNPSNSWPSPTEPSSETGN
PRHLHVLIGTSVVIILFILLLFFLLHRWCCNKKNAVVMDQEPAGNRTVNREDSDEQDPQEVTYAQLNHCVFTQRKITRPS
QRPKTPPTDIIVYTELPNAEP
22
245
1B6U
1
224
P43628
A
1
1
224
2
2
4
3
3
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
LEU
17
A
LEU
17
A
LYS
19
A
LYS
19
A
VAL
100
A
VAL
100
A
THR
102
A
THR
102
A
VAL
24
A
VAL
24
A
SER
30
A
SER
30
A
SER
60
A
SER
60
A
ILE
66
A
ILE
66
A
ASP
47
A
ASP
47
A
ILE
52
A
ILE
52
A
HIS
36
A
HIS
36
A
GLU
42
A
GLU
42
A
GLY
75
A
GLY
75
A
SER
82
A
SER
82
A
LEU
97
A
LEU
97
A
ILE
99
A
ILE
99
A
SER
109
A
SER
109
A
SER
111
A
SER
111
A
SER
123
A
SER
123
A
SER
130
A
SER
130
A
PHE
160
A
PHE
160
A
PRO
168
A
PRO
168
A
MET
136
A
MET
136
A
ARG
141
A
ARG
141
A
GLY
173
A
GLY
173
A
SER
180
A
SER
180
A
LEU
195
A
LEU
195
A
VAL
197
A
VAL
197
179
P 65 2 2